MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to demonstrate hyperpolarized xenon (HXe) as a medical
imaging drug (agent) for Magnetic Resonance Imaging (MRI) of the human lung ventilation.
Phase:
Phase 2
Details
Lead Sponsor:
Xemed LLC
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) National Institutes of Health (NIH) University of Virginia